Drug Information

Drug General Information
Drug ID
D02BZV
Former ID
DNC007745
Drug Name
BMS-1
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529859]
Formula
C29H30FN3O2
Canonical SMILES
CC1=NC(=C(N1CCCCCCNC(=O)OC2=CC=CC=C2F)C3=CC=CC=C3)C4=CC<br />=CC=C4
InChI
1S/C29H30FN3O2/c1-22-32-27(23-14-6-4-7-15-23)28(24-16-8-5-9-17-24)33(22)21-13-3-2-12-20-31-29(34)35-26-19-11-10-18-25(26)30/h4-11,14-19H,2-3,12-13,20-21H2,1H3,(H,31,34)
InChIKey
LHAHTHILLRCRBM-UHFFFAOYSA-N
PubChem Compound ID
9956414
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529859]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529859J Med Chem. 2009 Jan 8;52(1):170-80.Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Ref 529859J Med Chem. 2009 Jan 8;52(1):170-80.Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.